Europe wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for Europe wound care biologics market are listed below;

MiMedx
Organogenesis Inc.
M?lnlycke Health Care AB
Integra Life Sciences
ConvaTec Inc.
BioHorizons IPH, Inc.
Anika Therapeutics, Inc.
Osiris Therapeutics, Inc.
Vericel Corporation
WRIGHT MEDICAL GROUP N.V.

The Europe wound care biologics market is segmented into;
Product Type
Wound Type
End User
?
On the basis of product type the Europe wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment isexpected to dominate the Europe wound care biologics market with highest market shares. However, allografts segment isexpected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa segment, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.
On the basis of wound type the Europe wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the Europe wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.
On the basis of end user Europe wound care biologics market is segmented into hospitals, wound care centres and ambulatory centers, clinics, community healthcare centers. In 2018, hospitals segment is expected to dominate the Europe wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.
Based on geography, the market is segmented into;
Germany
France
U.K.
Spain
Italy
Switzerland
Netherlands
Russia
Turkey
Belgium
Rest of Europe
Covered in this report
The report covers the present scenario and the growth prospects of the Europe wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.